Total Payments
$28,276
2024 Payments
$6,681
Companies
82
Transactions
944
Medicare Patients
755
Medicare Billing
$84,721
Payment Breakdown by Category
Food & Beverage$19,944 (70.5%)
Other$7,457 (26.4%)
Education$875.55 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,944 | 916 | 70.5% |
| Honoraria | $4,470 | 3 | 15.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,890 | 1 | 6.7% |
| Long term medical supply or device loan | $1,097 | 11 | 3.9% |
| Education | $875.55 | 13 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pharmacosmos Therapeutics Inc. | $4,491 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,368 | 69 | $0 (2024) |
| ARRAY BIOPHARMA INC | $2,304 | 24 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,042 | 49 | $0 (2024) |
| PFIZER INC. | $1,019 | 63 | $0 (2024) |
| Incyte Corporation | $993.26 | 44 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $951.03 | 47 | $0 (2024) |
| Celgene Corporation | $896.87 | 35 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $817.68 | 56 | $0 (2024) |
| Astellas Pharma US Inc | $766.94 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,681 | 252 | Novartis Pharmaceuticals Corporation ($1,468) |
| 2023 | $5,386 | 248 | Novartis Pharmaceuticals Corporation ($394.11) |
| 2022 | $4,395 | 214 | Novartis Pharmaceuticals Corporation ($351.10) |
| 2021 | $7,521 | 161 | Pharmacosmos Therapeutics Inc. ($2,070) |
| 2020 | $3,705 | 64 | Pharmacosmos Therapeutics Inc. ($2,400) |
| 2019 | $245.89 | 2 | Celgene Corporation ($124.29) |
| 2017 | $341.38 | 3 | Pharmacyclics LLC, An AbbVie Company ($248.04) |
All Payment Transactions
944 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.10 | General |
| Category: Hematology/Oncology | ||||||
| 12/19/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Genetically Defined Disease | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Oncology | ||||||
| 12/16/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: HORMONE THERAPY | ||||||
| 12/12/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug), Somatuline Depot | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TALVEY (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $34.69 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 12/10/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $42.34 | General |
| 12/09/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.85 | General |
| 12/09/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/02/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 12/02/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 485 | 1,336 | $120,285 | $44,960 |
| 2022 | 4 | 115 | 221 | $46,750 | $16,206 |
| 2021 | 7 | 125 | 195 | $50,299 | $20,485 |
| 2020 | 2 | 30 | 43 | $10,977 | $3,070 |
Total Patients
755
Total Services
1,795
Medicare Billing
$84,721
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 196 | $53,447 | $19,510 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 122 | $23,519 | $8,363 | 35.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 19 | 46 | $13,776 | $5,339 | 38.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 23 | $6,473 | $2,477 | 38.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 21 | $4,925 | $2,093 | 42.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 15 | 29 | $4,250 | $1,699 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,847 | $1,390 | 36.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 111 | 167 | $2,742 | $1,385 | 50.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 11 | $2,205 | $742.61 | 33.7% |
| 36591 | Collection of blood sample from implanted device | Office | 2023 | 13 | 31 | $1,919 | $725.79 | 37.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 17 | 26 | $1,668 | $625.98 | 37.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 46 | $1,335 | $542.20 | 40.6% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 11 | 336 | $66.70 | $24.13 | 36.2% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 16 | 27 | $53.65 | $21.44 | 40.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 14 | 244 | $57.46 | $20.89 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 93 | $26,455 | $9,187 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 72 | $14,544 | $5,013 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $5,505 | $1,884 | 34.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 18 | 41 | $246.00 | $121.35 | 49.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 62 | $16,282 | $7,077 | 43.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 25 | $9,329 | $3,740 | 40.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 43 | $7,917 | $3,305 | 41.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 16 | $4,255 | $1,860 | 43.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 18 | $3,667 | $1,590 | 43.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $5,115 | $1,552 | 30.3% |
About Dr. Nawid Sarwari, M.D
Dr. Nawid Sarwari, M.D is a Hematology & Oncology healthcare provider based in Anaheim, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1649698630.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nawid Sarwari, M.D has received a total of $28,276 in payments from pharmaceutical and medical device companies, with $6,681 received in 2024. These payments were reported across 944 transactions from 82 companies. The most common payment nature is "Food and Beverage" ($19,944).
As a Medicare-enrolled provider, Sarwari has provided services to 755 Medicare beneficiaries, totaling 1,795 services with total Medicare billing of $84,721. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Anaheim, CA
- Active Since 04/07/2014
- Last Updated 07/08/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1649698630
Products in Payments
- Monoferric (Drug) $4,470
- BRAFTOVI (Drug) $2,198
- KISQALI (Drug) $1,957
- KEYTRUDA (Biological) $969.59
- Lenvima (Drug) $752.90
- OPDIVO (Biological) $541.96
- JAKAFI (Drug) $467.07
- IMBRUVICA (Drug) $420.52
- CABOMETYX (Drug) $383.96
- Enhertu (Drug) $382.20
- Stivarga (Drug) $366.39
- MONJUVI (Drug) $355.94
- ZEJULA (Drug) $354.36
- REBLOZYL (Biological) $350.86
- XPOVIO (Drug) $349.34
- Pomalyst (Drug) $318.39
- BRUKINSA (Drug) $295.93
- Imbruvica (Drug) $272.76
- LIBTAYO (Biological) $263.45
- XTANDI (Drug) $256.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Anaheim
Dr. Jayaram Bharadwaj, M.d, M.D
Hematology & Oncology — Payments: $19,683
Hematology & Oncology $19,683
Ms. Sharon Westerberg, Pa-C, PA-C
Hematology & Oncology — Payments: $13,846
Hematology & Oncology $13,846
Dr. Baijia Jiang, M.d, M.D
Hematology & Oncology — Payments: $10,554
Hematology & Oncology $10,554
Dr. Van Nguyen, M.d, M.D
Hematology & Oncology — Payments: $1,102
Hematology & Oncology $1,102
Farah Brasfield, Md, MD
Hematology & Oncology — Payments: $935.00
Hematology & Oncology $935.00
Dr. Charng Chong, M.d, M.D
Hematology & Oncology — Payments: $504.53
Hematology & Oncology $504.53